ArticleAnnals of translational medicine2023

A gene signature driven by abnormally methylated DEGs was developed for TP53 wild-type ovarian cancer samples by integrative omics analysis of DNA methylation and gene expression data.

Zhu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.